{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:37:29Z","timestamp":1761561449513},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s12664-010-0032-1","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T08:39:22Z","timestamp":1279960762000},"page":"106-111","source":"Crossref","is-referenced-by-count":6,"title":["Statin use does not prevent recurrent adenomatous polyp formation in a VA population"],"prefix":"10.1007","volume":"29","author":[{"given":"Nikki","family":"Parker-Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehad","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen K.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,25]]},"reference":[{"key":"32_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71\u201396.","journal-title":"CA Cancer J Clin"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","volume":"294","author":"AT Chan","year":"2005","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005;294:914\u201323.","journal-title":"JAMA"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-140-3-200402030-00006","volume":"140","author":"AT Chan","year":"2004","unstructured":"Chan AT, Giovannucci EL, Schernhammer ES, et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med. 2004;140:157\u201366.","journal-title":"Ann Intern Med"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(99)70342-2","volume":"117","author":"B Agarwal","year":"1999","unstructured":"Agarwal B, Rao CV, Bhendwal S, et al. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology. 1999;117:838\u201347.","journal-title":"Gastroenterology"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0140-6736(92)90744-N","volume":"339","author":"H Buchwald","year":"1992","unstructured":"Buchwald H. Cholesterol inhibition, cancer, and chemotherapy. Lancet. 1992;339:1154\u20136.","journal-title":"Lancet"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1349-7006.1996.tb02103.x","volume":"87","author":"T Narisawa","year":"1996","unstructured":"Narisawa T, Morotomi M, Fukaura Y, Hasebe M, Ito M, Aizawa R. Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res. 1996;87:798\u2013804.","journal-title":"Jpn J Cancer Res"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.leu.2402476","volume":"16","author":"WW Wong","year":"2002","unstructured":"Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002;16:508\u201319.","journal-title":"Leukemia"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.295.1.74","volume":"295","author":"KM Dale","year":"2006","unstructured":"Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Statins and cancer risk: a meta-analysis. JAMA. 2006;295:74\u201380.","journal-title":"JAMA"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1055-9965.EPI-03-0080","volume":"14","author":"JT Wei","year":"2005","unstructured":"Wei JT, Mott LA, Baron JA, Sandler RS. Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005;14:1026\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1200\/JCO.2007.10.8936","volume":"25","author":"S Bonovas","year":"2007","unstructured":"Bonovas S, Filioussi K, Flordellis CS, Sitaras NM. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol. 2007;25:3462\u20138.","journal-title":"J Clin Oncol"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","volume":"35","author":"TC Wenig","year":"2010","unstructured":"Wenig TC, Yang YH, Lin SJ, Tai SH. A systematic review and meta-analysis on the therapeutic equivalence of statins. J Clin Pharm Ther. 2010;35:139\u201351.","journal-title":"J Clin Pharm Ther"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.1997.v112.agast970594","volume":"112","author":"SJ Winawer","year":"1997","unstructured":"Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594\u2013642.","journal-title":"Gastroenterology"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ijc.20758","volume":"114","author":"S Friis","year":"2005","unstructured":"Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer. 2005;114:643\u20137.","journal-title":"Int J Cancer"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.106.650176","volume":"115","author":"S Setoguchi","year":"2007","unstructured":"Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007;115:27\u201333.","journal-title":"Circulation"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jnci\/djj006","volume":"98","author":"EJ Jacobs","year":"2006","unstructured":"Jacobs EJ, Rodriguez C, Brady KA, Connell CJ, Thun MJ, Calle EE. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst. 2006;98:69\u201372.","journal-title":"J Natl Cancer Inst"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/djm286","volume":"100","author":"WR Farwell","year":"2008","unstructured":"Farwell WR, Scranton RE, Lawler EV, et al. The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst. 2008;100:134\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"32_CR17","unstructured":"Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975\u20132005. National Cancer Institute, 2008."},{"key":"32_CR18","unstructured":"Hoffman RM, Stone SN, Viera RL, New Mexico Cancer Facts and Figures. New Mexico Department of Health, 2007 [monograph online]. Available from URL: http:\/\/www.cancernm.org\/cancercouncil\/facts_figures.htm [Accessed May 22, 2010]."},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","volume":"97","author":"SC Larsson","year":"2005","unstructured":"Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:1679\u201387.","journal-title":"J Natl Cancer Inst"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-07-0199","volume":"16","author":"JH Kim","year":"2007","unstructured":"Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev. 2007;16:1543\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","volume":"132","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132:2208\u201325.","journal-title":"Gastroenterology"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","volume":"352","author":"JN Poynter","year":"2005","unstructured":"Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer. N Engl J Med. 2005;352:2184\u201392.","journal-title":"N Engl J Med"},{"key":"32_CR23","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective, 2007 [monograph online]. Available from URL: http:\/\/www.dietandcancerreport.org\/ [accessed March 17, 2009]."},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/dji267","volume":"97","author":"SL Zielinski","year":"2005","unstructured":"Zielinski SL. Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention. J Natl Cancer Inst. 2005;97:1172\u20133.","journal-title":"J Natl Cancer Inst"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-010-0032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-010-0032-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-010-0032-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:47:48Z","timestamp":1559483268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-010-0032-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s12664-010-0032-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}